<DOC>
	<DOCNO>NCT02804204</DOCNO>
	<brief_summary>Multicenter , prospective , observational study evaluate circulant rheumatoid factor , cyclic citrullinated anti-peptide anti-bodies albumin use potential predictor response treatment anti-TNF patient rheumatoid arthritis 24 week treatment .</brief_summary>
	<brief_title>Serum Biomarkers Analysis Patients With AR Treated With Anti-TMF</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Both gender Over 18 year old Diagnosis rheumatoid arthritis accord ACR criterion Patients initiate treatment antiTNF drug accord clinical practice , na√Øve antiTNF patient patient first antiTNF failure Patients able follow protocol requirement Patients sign informed consent Patients know hypersensitivity investigational product Patients tuberculosis , severe infection like sepsis opportunistic infection Patients moderate/severe cardiac insufficiency ( NHYA classification Class III/IV ) Patients accord investigator criterion participate study complete study questionnaire Pregnant fertile woman use contraception method</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>